Douglas Janzen

Douglas Janzen

Algemeen Directeur bij AEQUUS PHARMACEUTICALS INC.

Vermogen: 12 554 $ op 30-06-2026

58 jaar
Health Technology
Finance
Commercial Services

Profiel

Douglas Glen Janzen is the founder of Aequus Pharmaceuticals, Inc., founded in 2013, serving as Chairman, President & Chief Executive Officer.
Mr. Janzen is the founder of Northview LifeSciences, founded in 2014.
Mr. Janzen is the founder of Northview Ventures & Associates General Partnership, founded in 2014, serving as Managing Director.
Current jobs include Chairman at Lexington Biosciences Holdings Corp.
since 2017, Director & Managing Director at LifeSciences British Columbia since 2010, Director at Synaptive Technologies Ltd., Director at Transdermal Research Pharm Laboratories LLC since 2013, and Director at Alabaster Technologies, Inc. Former jobs include President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2010 to 2012, Chairman at AbCellera Biologics, Inc., Chairman at Lexington Biosciences, Inc. from 2016 to 2021, Chairman at Perimeter Medical Imaging, Inc., Director at Medical Ventures Corp., Director at Teal Valley Health, Inc., Director at Aptamera, Inc., Director at Synaptive Medical, Inc., Director at BIOTECanada, Independent Director at iCo Therapeutics, Inc. from 2012 to 2015, Director at Sentinelle Medical ULC, Independent Director at Neovasc, Inc., Director at BioHEP Technologies Ltd., Director at Renaissance BioScience Corp., Director at AmpHP, Inc., Director at Perimeter Medical Imaging AI, Inc., Analyst at Cormark Securities, Inc. in 2002, President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007, and Head of Research at Loewen, Ondaatje, McCutcheon Ltd. in 2001.
Education includes graduate degree from the University of British Columbia and undergraduate degree from the University of Saskatchewan.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
24-09-2025 12.553.800 ( 9,46% ) 12 554 $ 30-06-2026

Actieve functies van Douglas Janzen

BedrijvenFunctieBegin
AEQUUS PHARMACEUTICALS INC. Algemeen Directeur 03-01-2013
Oprichter 01-04-2014
Alabaster Technologies, Inc.
Directeur/Bestuurslid -
Voorzitter 23-05-2017
Directeur/Bestuurslid 03-03-2013
Synaptive Technologies Ltd.
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Oprichter 01-04-2014

Eerdere bekende functies van Douglas Janzen

BedrijvenFunctieEinde
REGISTERED PLAN PRIVATE INVESTMENTS INC. Voorzitter 01-12-2021
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Douglas Janzen in detail bekijken

Opleiding van Douglas Janzen

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

50

Eerstegraads connecties

29

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit29

Finance

Health Technology

Electronic Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Commercial Services

Health Technology

Alabaster Technologies, Inc.

Health Technology

Health Technology

Health Technology

Finance

  1. Beurs
  2. Insiders
  3. Douglas Janzen